What are the dosing guidelines, contraindications, drug interactions, side effects, and safety considerations for fexofenadine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Fexofenadina (Fexofenadine)

Fexofenadine is a highly selective second-generation antihistamine that should be your preferred choice for allergic rhinitis and chronic urticaria because it provides effective symptom relief without causing sedation, cognitive impairment, or cardiac effects, even at doses exceeding recommendations. 1

Dosing Guidelines

Adults and Children ≥12 years

  • Seasonal Allergic Rhinitis: 60 mg twice daily OR 120 mg once daily 2
  • Chronic Idiopathic Urticaria: 180 mg once daily 3, 4
  • Rapid onset of action ≤2 hours 3
  • Take with water only—avoid fruit juices 2

Children 6 months to 2 years

  • 15 mg or 30 mg twice daily (mixed with standard vehicle) 5
  • Well tolerated with safety profile comparable to placebo 5

Children 2-11 years

  • Limited specific dosing data in provided evidence, but second-generation antihistamines including fexofenadine show excellent safety profiles in young children 1, 6

Key Safety Advantages

Fexofenadine stands apart from other second-generation antihistamines because it causes NO sedation at recommended doses—unlike cetirizine and intranasal azelastine which DO cause sedation. 1 This distinction is critical:

  • Zero brain penetration: PET studies confirm no H1-receptor occupancy in the brain 7
  • No sedation even at 800 mg (>10× recommended dose) 2, 8
  • No cognitive or psychomotor impairment at any dose 3, 7, 4
  • No cardiac effects: No QTc prolongation even at 690 mg twice daily for 28 days 8

In contrast, loratadine and desloratadine may cause sedation at higher-than-recommended doses, while cetirizine causes sedation at standard doses (13.7% vs 6.3% placebo). 1

Contraindications and Precautions

  • Hypersensitivity to fexofenadine or any component 2
  • Pregnancy/Lactation: Use only if benefit justifies risk (no human epidemiologic studies published, though animal studies negative for teratogenicity) 1
  • Renal/Hepatic impairment: Well tolerated but use clinical judgment 4

Critical Drug Interactions

Avoid or Separate Timing:

  • Antacids (aluminum/magnesium): Decrease fexofenadine absorption by 41% (AUC) and 43% (Cmax). Do NOT take within 15 minutes of antacids 2
  • Fruit juices (grapefruit, orange, apple): Reduce bioavailability by 36%. Take with water only 2

Interactions That Increase Fexofenadine Levels (but are safe):

  • Erythromycin: Increases Cmax by 82%, AUC by 109% 2
  • Ketoconazole: Increases Cmax by 135%, AUC by 164% 2

These increases remain within safe therapeutic ranges with no cardiac or adverse effects observed. The mechanism involves enhanced GI absorption via p-glycoprotein transport effects. 2

Side Effects

Fexofenadine's adverse event profile is indistinguishable from placebo. 3, 4, 5

  • Most common: Headache (similar incidence to placebo) 3
  • In children 6 months-2 years: Vomiting most common (comparable to placebo rates) 5
  • No anticholinergic effects (dry mouth, constipation, urinary retention) 1
  • No performance impairment or next-day drowsiness 1

Clinical Efficacy

  • Equal efficacy to loratadine 10 mg and cetirizine 10 mg for seasonal allergic rhinitis 3
  • Superior quality of life improvement compared to loratadine (clinically meaningful difference) 3
  • Effective for sneezing, rhinorrhea, itchy nose/throat/eyes, and watery/red eyes 1, 3
  • Modest improvement in nasal congestion (less effective than intranasal corticosteroids for this symptom) 1
  • Effective for chronic urticaria up to 6 weeks at 180 mg daily 3

Special Populations

Older Adults

Fexofenadine is ideal because first-generation antihistamines cause increased fall risk, fractures, subdural hematomas, and cognitive impairment in elderly patients. 1

Pregnancy

While no human studies exist, animal data are reassuring. However, accumulated safety data for cetirizine and loratadine are more robust. 1 Use fexofenadine only if these alternatives are ineffective.

Young Children

Excellent safety profile demonstrated in children as young as 6 months, unlike OTC cough/cold medications which caused 54 decongestant-related and 69 antihistamine-related fatalities in children <6 years between 1969-2006. 1

Practical Prescribing Algorithm

  1. First-line for allergic rhinitis or urticaria: Start fexofenadine 60 mg twice daily or 120 mg once daily
  2. Instruct patient: Take with water only, avoid fruit juices and antacids within 2 hours
  3. If inadequate response: Can safely increase up to 240 mg daily (though off-label) 1
  4. If excessive nasal congestion: Add pseudoephedrine or switch to intranasal corticosteroid 1, 3
  5. Continuous use most effective, but appropriate for as-needed use due to rapid onset 1

Overdose Management

Doses up to 800 mg studied without significant adverse events. Overdose symptoms may include dizziness, drowsiness, dry mouth. Hemodialysis ineffective (removes only 1.7%). Use supportive care. 2

References

Guideline

the diagnosis and management of rhinitis: an updated practice parameter.

Journal of Allergy and Clinical Immunology, 2008

Research

The systemic safety of fexofenadine HCl.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology, 1999

Research

Safety and tolerability of fexofenadine hydrochloride, 15 and 30 mg, twice daily in children aged 6 months to 2 years with allergic rhinitis.

Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology, 2007

Research

Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis.

Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2021

Research

Cardiovascular safety of fexofenadine HCl.

The American journal of cardiology, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.